Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1–50 of 77097
On October 5, 2026, Brent Pope notified AgEagle Aerial Systems Inc. (the “Company”) of his intention to retire from his position as Chief Operating Officer of the Company, effective November 30, 2026.
On October 6, 2026, the Board of Directors (the “Board”) of Sidus Space, Inc. (the “Company”) received the resignation letter of Tiffany Norwood, pursuant to which Ms. Norwood resigned from the Board and as Audit Committee Chairwoman and as a member of the Corporate Governance/Nominating Committee, effective October 6, 2026 at 7:15 p.m. ET.
On October 6, 2026, the Board of the Company received the resignation letter of Kelle Wendling, pursuant to which Ms. Wendling resigned from the Board and as a member of the Audit Committee, Compensation Committee and Corporate Governance/Nominating Committee, effective October 6, 2026 at 1:00 p.m. ET.
On October 5, 2026, Mr. Chad Corbin notified Ross Tannenbaum, the Chief Executive Officer of NextBoat Inc. (the “Company”), of his decision to resign as Chief Financial Officer (the “CFO”) of the Company. Mr. Corbin will continue to serve as CFO during a transition period until a successor CFO is identified. Mr. Corbin’s resignation did not result from any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
The employment of Michael Fiore, the Chief Commercial Officer at HealthEquity, Inc. (the “Company”), was terminated by the Company without cause, effective October 5, 2026.
In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, each of Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased to serve as a member of the Board of Directors of the Company (the “Board”) and of any committee of the Board, and Krystal Eckhart ceased to serve as Interim Chief Financial Officer of the Company.
In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, Abraham Schwartz and Zalman Schapiro, being the directors of Merger Sub immediately prior to the Effective Time, became the directors of the Company, and Abraham Schwartz and Zalman Schapiro, being the officers of Merger Sub immediately prior to the Effective Time, became the officers of the Company.
and Abraham Schwartz and Zalman Schapiro, being the officers of Merger Sub immediately prior to the Effective Time, became the officers of the Company.
In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, Abraham Schwartz and Zalman Schapiro, being the directors of Merger Sub immediately prior to the Effective Time, became the directors of the Company, and Abraham Schwartz and Zalman Schapiro, being the officers of Merger Sub immediately prior to the Effective Time, became the officers of the Company.
In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, each of Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased to serve as a member of the Board of Directors of the Company (the “Board”) and of any committee of the Board, and Krystal Eckhart ceased to serve as Interim Chief Financial Officer of the Company.
In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, each of Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased to serve as a member of the Board of Directors of the Company (the “Board”) and of any committee of the Board, and Krystal Eckhart ceased to serve as Interim Chief Financial Officer of the Company.
and Abraham Schwartz and Zalman Schapiro, being the officers of Merger Sub immediately prior to the Effective Time, became the officers of the Company.
In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, each of Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased to serve as a member of the Board of Directors of the Company (the “Board”) and of any committee of the Board, and Krystal Eckhart ceased to serve as Interim Chief Financial Officer of the Company.
Effective on October 9, 2026, Hiral A. Patel, the Company’s current Chief Accounting Officer and Principal Accounting Officer, was appointed the Company’s Principal Financial Officer.
On October 9, 2026, William H. White was terminated as Chief Financial Officer and Principal Financial Officer of Quantum Corporation (the “Company”) effective immediately.
On October 9, 2026, Mitek Systems, Inc. (the “Company”), announced that the employment of Michael E. Diamond, Senior Vice President of Sales, Check Verification and one of the Company’s named executive officers for fiscal year 2026, will terminate on December 8, 2026.
Effective as of the open of business on October 9, 2026, Joseph M. Cohen was appointed as a director of MSGS Spinco, Inc. (the “Company”) by the Company’s Board of Directors (the “Board”).
On October 1, 2026, The Goodyear Tire & Rubber Company (the “Company”) filed a Current Report on Form 8-K announcing the election of Stephen F. Shamrock as Vice President and Controller, effective October 16, 2026.
On October 9, 2026, the board of directors (the “Board”) of the Company appointed Gary Stetz, the Company’s former Interim Chief Executive Officer, to serve as the Company’s Chief Financial Officer, and Sireesh Appajosyula, PharmD, the former Chief Executive Officer of Gravitas Life Sciences, LLC, to serve as the Company’s Chief Executive Officer, in each case effective as of October 9, 2026.
On October 9, 2026, the board of directors (the “Board”) of the Company appointed Gary Stetz, the Company’s former Interim Chief Executive Officer, to serve as the Company’s Chief Financial Officer, and Sireesh Appajosyula, PharmD, the former Chief Executive Officer of Gravitas Life Sciences, LLC, to serve as the Company’s Chief Executive Officer, in each case effective as of October 9, 2026.
On October 8, 2026, the Board of Directors (the “Board”) of TOP Financial Group Limited (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, increased the size of the Board from five to seven directors and appointed Mr. Dean Huge as an independent director of the Company, effective October 8, 2026.
On October 8, 2026, the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Ms. Yuli Yan as an executive director of the Company, effective October 8, 2026.
On October 8, 2026, Fluence Energy, Inc. (“the Company”, “we” or “our”) and Peter Williams, our former Senior Vice President and Chief Product Officer, entered into a separation agreement and release of claims (the “Williams Separation Agreement”).
On October 9, 2026, Brian Dostie, principal accounting officer of BARK, Inc. (the “Company”), notified the Company of his decision to resign from the Company, effective October 23, 2026, to pursue another professional opportunity. Mr. Dostie ceased serving as the Company’s principal accounting officer effective October 9, 2026.
As previously disclosed, Anya Hamill has served as the Company’s Chief Financial Officer and principal financial officer since September 8, 2026. In connection with Mr. Dostie’s resignation, the Company has designated Ms. Hamill to also serve as the Company’s principal accounting officer, effective October 9, 2026.
The Consents, in part, removed from the Company’s Board of Directors (the “Board”) without cause each of Daniel Lewis, Arnaud Massenet, Bhaskar Menon, Prabhu Narasimhan and Harit Talwar, effective immediately (the “Removal”).
On October 5, 2026, Mr. Garg, in his capacity as the sole remaining director of the Company following the Removal and resignation described above, appointed Bing Gordon, Steven Sarracino, Paula Tuffin, the Company’s General Counsel, Chief Compliance Officer and Secretary, and Nicholas Calamari, an employee of the Company, to the Board to fill existing vacancies.
The Consents, in part, removed from the Company’s Board of Directors (the “Board”) without cause each of Daniel Lewis, Arnaud Massenet, Bhaskar Menon, Prabhu Narasimhan and Harit Talwar, effective immediately (the “Removal”).
On October 1, 2026, Hugh Frater notified the Company of his decision to resign from the Board, effective upon the Removal. Mr. Frater’s decision to resign was the result of the outcome of the consent solicitation conducted by the Garg Group to remove without cause certain other directors from the Board, as further described in this Current Report on Form 8-K.
On October 5, 2026, Mr. Garg, in his capacity as the sole remaining director of the Company following the Removal and resignation described above, appointed Bing Gordon, Steven Sarracino, Paula Tuffin, the Company’s General Counsel, Chief Compliance Officer and Secretary, and Nicholas Calamari, an employee of the Company, to the Board to fill existing vacancies.
On October 5, 2026, following the director appointments described above, the Board removed Daniel Lewis as Interim Chief Executive Officer, effective immediately. The Board has commenced a process to identify and appoint a successor Interim Chief Executive Officer.
The Consents, in part, removed from the Company’s Board of Directors (the “Board”) without cause each of Daniel Lewis, Arnaud Massenet, Bhaskar Menon, Prabhu Narasimhan and Harit Talwar, effective immediately (the “Removal”).
The Consents, in part, removed from the Company’s Board of Directors (the “Board”) without cause each of Daniel Lewis, Arnaud Massenet, Bhaskar Menon, Prabhu Narasimhan and Harit Talwar, effective immediately (the “Removal”).
On October 5, 2026, Mr. Garg, in his capacity as the sole remaining director of the Company following the Removal and resignation described above, appointed Bing Gordon, Steven Sarracino, Paula Tuffin, the Company’s General Counsel, Chief Compliance Officer and Secretary, and Nicholas Calamari, an employee of the Company, to the Board to fill existing vacancies.
On October 5, 2026, Mr. Garg, in his capacity as the sole remaining director of the Company following the Removal and resignation described above, appointed Bing Gordon, Steven Sarracino, Paula Tuffin, the Company’s General Counsel, Chief Compliance Officer and Secretary, and Nicholas Calamari, an employee of the Company, to the Board to fill existing vacancies.
The Consents, in part, removed from the Company’s Board of Directors (the “Board”) without cause each of Daniel Lewis, Arnaud Massenet, Bhaskar Menon, Prabhu Narasimhan and Harit Talwar, effective immediately (the “Removal”).
On October 6, 2026, Myriad Genetics, Inc. (the “Company”) entered into a Separation Agreement and Release of Claims (the “Separation Agreement”) with Brian Donnelly, the Company’s former Chief Commercial Officer. As previously disclosed, Mr. Donnelly departed from his position as Chief Commercial Officer of the Company, effective September 16, 2026.
On October 6, 2026, Donna F. Zarcone informed the Board of Directors (the “Board”) of The Cigna Group (the “Company”) that she will retire from the Board effective December 31, 2026.
On October 9, 2026, W. Kimball Griffith informed the Board of Managers (the “ Board ”) of Greystone AF Manager LLC, a Delaware limited liability company (the “ Company ”), of his decision to retire as a member of the Board of the Company, effective as of October 9, 2026.
On October 9, 2026, the Company’s Board of Directors (the “Board”) appointed Michael Cochran, age 39, as interim Chief Financial Officer, effective as of October 10, 2026.
On October 9, 2026, following the completion of Phoenix Education Partners, Inc.’s (the “Company”) first full year as a public company after its successful IPO, the Company and Blair Westblom, Chief Financial Officer and Treasurer of the Company, agreed that Ms. Westblom will separate from the Company, effective as of October 10, 2026, to focus on personal endeavors and her next professional chapter.
On October 7, 2026, the Board of Directors (“Board”) of Cisco Systems, Inc. (“Cisco”) appointed Girish D. Rishi, CEO of Cognite Holding B.V., as a member of the Board effective October 9, 2026.
previously reported resignation of Katharyn Field as a director effective August 31, 2026.
On October 7, 2026, the Board of Directors (the “ Board ”) of BioRestorative Therapies, Inc. (the “ Company ”) appointed Donald J. Currie as a Class I director of the Company, effective immediately, to fill the vacancy created by the previously reported resignation of Katharyn Field as a director effective August 31, 2026.
As previously disclosed in a Current Report on Form 8-K filed by Pool Corporation (“the Company”) on January 12, 2026, Kenneth G. St. Romain informed the company of his decision to retire as Senior Vice President at a future unspecified date during 2026. On October 5, 2026, the Company announced the effective date of Mr. St. Romain’s retirement as Senior Vice President as December 31, 2026.
On October 8, 2026, Helder Antunes tendered his resignation as a director of Veea Inc. (the “ Company ”), effective immediately, and Mr. Antunes will continue to serve as an Executive Vice President and Chief Revenue Officer of the Company.
On October 6, 2026, the Board appointed Talbott Roche to serve as a member of the Board effective immediately.
On October 6, 2026, Aidin Aghamiri notified Plum Acquisition Corp. IV (the “Company”) of his resignation as a member of the Company's board of directors (the “Board”), effective immediately. Mr. Aghamiri's resignation was not the result of any disagreement with the Company or the Board on any matter relating to the Company's operations, policies or practices.
Richard Gorman resigned from the Board of Directors (“Board”) of the Company and from all committees of the Board on which he served, including the Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee, effective October 12, 2026.
concurrent with his becoming an employee of Vogenx, Inc. (the “Company”) as Chief Commercial Officer
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.